27 April 2021 in International Journal of Endorsing Health Science Research (IJEHSR)
Background: Recent evidence suggests olfactory and gustatory sensory deficits among Coronavirus Disease 2019 (COVID-19) patients. It is important to assess the occurrence of anosmia and ageusia among infected individuals as it may be the potential symptom and assist in controlling the viral load. The objective of the present study was to determine the prevalence of ageusia and anosmia among COVID-19 patients admitted to the teaching hospitals of District Bannu and Swat-Pakistan. Methodology: This retrospective cohort study was conducted between April to November 2020. A total of 100 confirmed COVID-19 cases, tested through polymerase chain reaction (PCR), were included in the study. Data including gender, age, smoking status, recent travelling history, nasal and paranasal disorder (NPND) history and COVID-19 severity were obtained from the patients’ records. The symptomatology, including frequency of anosmia and ageusia was recorded. Results: Out of 100 patients, 43.75% of patients had anosmia and 31.25% had ageusia, while 68% of patients were presented without olfactory and gustatory dysfunction. Most of the enrolled patients had no recent travel history (91.46%) and none of them were asymptomatic. Moreover, 88% of patients with a previous history of NPND did not have olfactory and gustatory dysfunction. Various characteristics features, including recent travel history, smoking, gender and disease severity, were significantly associated with anosmia and ageusia. Conclusion: The COVID-19 patients were exclusively suffering from ageusia and anosmia. It can be concluded that amongst asymptomatic-to-mild disease severity patients, the existence of smell and taste might be an important differential demonstration for the apprehension and analysis of COVID-19.
24 April 2021 in International Journal of Endorsing Health Science Research (IJEHSR)
Background: Nasal polyps were believed to be small tumours of nasal or sinus mucosa. With progressing research, they are associated with enlargement or swelling of nasal or sinus mucosa, allergy, asthma, any infection, sensitivity to aspirin, and/or cystic fibrosis unclear etiology. The present study aims to evaluate the prevalence of fungal infections that can result in the onset of nasal polyposis in the residents of district Bannu, Pakistan. Methodology: A cross-sectional study was conducted at the ENT Department of Khalifa Gul Nawaz (KGN) teaching hospital in Bannu from March 2018 to February 2020, including 180 polyposis patients with the presence or absence of any fungal infestation. The subjects possessing mass other than nasal polyp based on clinical diagnosis were excluded from the study. The fungal infestation was observed with nasal endoscopy, and the patients were hospitalized for functional endoscopic sinus surgery (FESS). The staging of the nasal polyposis was based on the CT scan findings. The condition was classified into three grades, i.e., grade I, II and III. The data was statistically analysed on SPSS version 20.0. Results: Out of 180 patients diagnosed clinically for nasal polyposis, 97(53.88%) were males. The fungal infestation was positive in 73(41%) specimens. Around 52.72% of patients were found with bilateral involvement. Of which, 31.57% were diagnosed with an allergic event. The fungus Aspergillus was observed in 40.55% of specimens. The one-year follow-up displayed an overall recurrence rate of 40%, i.e., 38(52.05%) patients from the fungal group and 34(47.22%) from the non-fungal group. Conclusion: It is concluded from the study outcomes that the incidence of nasal polyposis with or without fungal infection is associated with the environment and the discrete host response. Moreover, individuals living with lower socioeconomic conditions in crowded and humid areas tend to suffer more.
15 August 2022 in International Journal of Endorsing Health Science Research (IJEHSR)
Background: Background: There is a lack of information regarding serum uric acid (SUA) and magnesium levels among the pre-diabetics population. This study aimed to assess the biochemical assessment of both uric acid and magnesium in prediabetics of the Peshawar-KP region. Methodology: In this case-control study, patients having normal glucose levels were considered as control, and prediabetics were cases. Fasting blood glucose (FPG) levels between 100-125 mg/dl or HbA1c levels between 5.7 to 6.4% were considered pre-diabetic. SUA was assessed by the Uricase method, serum Mg+ by the Calmagite calorimetric method, and fasting glucose was assessed by the GOD-POD enzymatic method. Results: According to our findings, mean values of serum magnesium were 2.12 ± 0.60 mg/dl (p=0.026) and 1.10 ± 0.82 mg/dl (p=0.001) in male and female of control group whereas, 1.60 ± 0.44 mg/dl (p=0.004) and 0.90 ± 0.22 mg/dl (p=0.002) in male and female of cases group respectively. Correspondingly, mean value of SUA was recorded as 4.14 ± 0.66 mg/dl (p=0.008) and 3.12 ± 0.38 mg/dl (p=0.004) in male and female of control group whereas 8.10 ± 1.00 mg/dl (p=0.002) and 6.22 ± 0.44 mg/dl (p=0.003) in male and female of cases and subjects group respectively. It is noticeable that mean serum magnesium and SUA values were higher in the male of both groups compared to females. Conclusion: The study concluded that lower serum magnesium levels in prediabetics might result from the closure of K+ channels, defective phosphorylation of insulin receptors, or diminished glucokinase activity. Higher uric acid levels in prediabetics might result from inflammation, oxidative stress, and hypertrophy of the tubules.
28 February 2022 in International Journal of Endorsing Health Science Research (IJEHSR)
Background: Impaired glycemic profile and cognitive impairment are generally associated with bipolar disorders. Patients on long-term use of psychotropic drugs are more prone to other medical abnormalities etc. The study's objective was to assess the glycemic and lipidemic profiles of patients with bipolar disorder reported at a tertiary care hospital in the Khyber Pakhtunkhwa-Pakistan. Methodology: This was a cross-sectional study conducted in a private hospital in Khyber Pakhtunkhwa from January 2020 to June 2021. A total of 400 patients were enrolled in the study, and the sample size was calculated using a WHO calculator. Blood tests were performed for high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), fasting glucose, and triglycerides (TG). Results: Of the total 400 enrolled patients, 84.0% (n=336) had a diagnosis of bipolar disorder while rest of the 16.0% (n=64) had Schizophrenia. No statistical difference was found in the metabolic parameters following the primary diagnosis. As for pharmacological parameters, patients with bipolar disorders were receiving more psychiatric medicines than schizophrenic patients with a p-value < 0.001. Conclusion: It is concluded that the levels of HDL, LDL, and total cholesterol were significantly elevated in the manic condition compared to the Euthymic phase and by improving their glycemic and lipidemic profiles, cognitive dysfunction might be rectified, and functioning can be improved.